| Literature DB >> 34790247 |
Xiaolu Wang1, Wenpeng Wei2, Yanyan Qi3, Lihua Dong4, Yun Zhang5.
Abstract
OBJECTIVE: This study is aimed to observe the clinical effects of integrated traditional Chinese and Western medicine in treating severe preeclampsia (SPE) and its effects on maternal and infant outcomes after cesarean section under combined lumbar and epidural anesthesia.Entities:
Year: 2021 PMID: 34790247 PMCID: PMC8592741 DOI: 10.1155/2021/6366914
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Comparison of clinical efficacy between the two groups of patients (n (%)).
| Group | Cases | Special effect | Valid | Invalid | Total effective rate |
|---|---|---|---|---|---|
| Experimental | 83 | 36 (43.37) | 39 (46.99) | 8 (9.64) | 75 (90.36) |
| Control | 83 | 19 (22.89) | 40 (48.19) | 24 (28.92) | 59 (71.08) |
|
| 13.267 | ||||
|
| 0.001 |
Figure 1Comparison of blood pressure, MAP, and 24 h PRO content between the two groups of patients after treatment. (a) The comparison of SBP after treatment of the two groups of patients. (b) The comparison of DBP after treatment of the two groups of patients. (c) The comparison of the MAP between the two groups of patients after treatment. (d) The comparison of PRO content of the two groups of patients at 24 h after treatment.
Figure 2Comparison of serum inflammatory factor levels before and after treatment between the two groups. (a) The comparison of Hcy levels between the two groups of patients before and after treatment. (b) The comparison of CRP levels between the two groups of patients before and after treatment. (c) The comparison of IL-6 levels before and after treatment in the two groups of patients. (d) The comparison of TNF-α levels before and after treatment in the two groups.
Comparison of stress indicators between the two groups of patients before and after treatment ().
| Indicators | Experimental | Control |
|
| |
|---|---|---|---|---|---|
| SOD (U/mL) | Before treatment | 83.66 ± 9.63 | 84.07 ± 9.73 | 0.264 | >0.05 |
| After treatment | 141.57 ± 6.34 | 113.28 ± 7.46 | 7.823 | <0.05 | |
|
| |||||
| GSH-Px (U/mL) | Before treatment | 98.37 ± 10.84 | 98.72 ± 10.21 | 0.665 | >0.05 |
| After treatment | 133.56 ± 8.71 | 110.42 ± 9.02 | 10.234 | <0.05 | |
|
| |||||
| MDA (mmol/L) | Before treatment | 9.23 ± 2.37 | 9.15 ± 2.64 | 0.456 | >0.05 |
| After treatment | 4.87 ± 1.13 | 7.23 ± 1.58 | 4.871 | <0.05 | |
|
| |||||
| LPO (nmol/L) | Before treatment | 15.87 ± 3.72 | 15.96 ± 3.45 | 0.674 | >0.05 |
| After treatment | 7.34 ± 2.23 | 12.62 ± 2.73 | 6.257 | <0.05 | |
|
| |||||
| AOPP ( | Before treatment | 31.36 ± 5.24 | 31.93 ± 5.48 | 0.931 | >0.05 |
| After treatment | 18.37 ± 3.66 | 25.89 ± 3.91 | 12.554 | <0.05 | |
Figure 3Comparison of renal function indexes of the two groups of patients before and after treatment. (a) The comparison of BUN levels between the two groups of patients before and after treatment. (b) The comparison of Scr levels between the two groups of patients before and after treatment. (c) The comparison of Alb levels between the two groups of patients before and after treatment. (d) The comparison of β2-MG levels before and after treatment in the two groups.
Comparison of maternal and infant outcomes between the two groups (n).
| Group | Cases | Placental abruption | Oligohydramnios | Uterine asthenia | Fetal distress | Neonatal asphyxia |
|---|---|---|---|---|---|---|
| Experimental | 83 | 6 | 4 | 5 | 4 | 2 |
| Control | 83 | 16 | 7 | 13 | 13 | 9 |
|
| 6.631 | 1.132 | 5.457 | 10.226 | 11.392 | |
|
| <0.05 | >0.05 | <0.05 | <0.05 | <0.05 |